Your browser doesn't support javascript.
loading
Functional and clinical studies reveal pathophysiological complexity of CLCN4-related neurodevelopmental condition.
Palmer, Elizabeth E; Pusch, Michael; Picollo, Alessandra; Forwood, Caitlin; Nguyen, Matthew H; Suckow, Vanessa; Gibbons, Jessica; Hoff, Alva; Sigfrid, Lisa; Megarbane, Andre; Nizon, Mathilde; Cogné, Benjamin; Beneteau, Claire; Alkuraya, Fowzan S; Chedrawi, Aziza; Hashem, Mais O; Stamberger, Hannah; Weckhuysen, Sarah; Vanlander, Arnaud; Ceulemans, Berten; Rajagopalan, Sulekha; Nunn, Kenneth; Arpin, Stéphanie; Raynaud, Martine; Motter, Constance S; Ward-Melver, Catherine; Janssens, Katrien; Meuwissen, Marije; Beysen, Diane; Dikow, Nicola; Grimmel, Mona; Haack, Tobias B; Clement, Emma; McTague, Amy; Hunt, David; Townshend, Sharron; Ward, Michelle; Richards, Linda J; Simons, Cas; Costain, Gregory; Dupuis, Lucie; Mendoza-Londono, Roberto; Dudding-Byth, Tracy; Boyle, Jackie; Saunders, Carol; Fleming, Emily; El Chehadeh, Salima; Spitz, Marie-Aude; Piton, Amelie; Gerard, Bénédicte.
Afiliação
  • Palmer EE; Centre for Clinical Genetics, Sydney Children's Hospital Network, Randwick, NSW, Australia. elizabeth.palmer@unsw.edu.au.
  • Pusch M; Discipline of Paediatrics and Child Health, Faculty of Medicine and Health, University of New South Wales, Randwick, NSW, Australia. elizabeth.palmer@unsw.edu.au.
  • Picollo A; Istituto di Biofisica, CNR, Genova, Italy. michael.pusch@ibf.cnr.it.
  • Forwood C; Istituto di Biofisica, CNR, Genova, Italy.
  • Nguyen MH; Centre for Clinical Genetics, Sydney Children's Hospital Network, Randwick, NSW, Australia.
  • Suckow V; Discipline of Paediatrics and Child Health, Faculty of Medicine and Health, University of New South Wales, Randwick, NSW, Australia.
  • Gibbons J; Department of Clinical Genetics, Liverpool Hospital, Liverpool, NSW, Australia.
  • Hoff A; Max Planck Institute for Molecular Genetics, Group Development and Disease, Berlin, Germany.
  • Sigfrid L; Max Planck Institute for Molecular Genetics, Group Development and Disease, Berlin, Germany.
  • Megarbane A; Istituto di Biofisica, CNR, Genova, Italy.
  • Nizon M; Department of Biomedical and Clinical Sciences, Linköping University, Linköping, 581 83, Sweden.
  • Cogné B; Istituto di Biofisica, CNR, Genova, Italy.
  • Beneteau C; Department of Biomedical and Clinical Sciences, Linköping University, Linköping, 581 83, Sweden.
  • Alkuraya FS; Department of Human Genetics, Gilbert and Rose-Marie Chagoury School of Medicine, Lebanese American University, Byblos, Lebanon.
  • Chedrawi A; Institut Jerome Lejeune, Paris, France.
  • Hashem MO; Service de Génétique Médicale, CHU de Nantes, Nantes Université, Nantes, France.
  • Stamberger H; Nantes Université, CNRS, INSERM, l'Institut du Thorax, Nantes, France.
  • Weckhuysen S; Service de Génétique Médicale, CHU de Nantes, Nantes Université, Nantes, France.
  • Vanlander A; Nantes Université, CNRS, INSERM, l'Institut du Thorax, Nantes, France.
  • Ceulemans B; Service de Génétique Médicale, CHU de Nantes, Nantes Université, Nantes, France.
  • Rajagopalan S; Department of Translational Genomics, Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
  • Nunn K; Department of Neurosciences, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
  • Arpin S; Department of Translational Genomics, Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
  • Raynaud M; Applied and Translational Neurogenomics Group, VIB Center for Molecular Neurology, VIB, Antwerp, Belgium.
  • Motter CS; Neurology Department, Antwerp University Hospital, Antwerp, Belgium.
  • Ward-Melver C; Applied and Translational Neurogenomics Group, VIB Center for Molecular Neurology, VIB, Antwerp, Belgium.
  • Janssens K; Neurology Department, Antwerp University Hospital, Antwerp, Belgium.
  • Meuwissen M; Translational Neurosciences, Faculty of Medicine and Health Science, University of Antwerp, Antwerp, Belgium.
  • Beysen D; Department of Child Neurology & Metabolism, Ghent University Hospital, Ghent, Belgium.
  • Dikow N; Department of Pediatric Neurology, Antwerp University Hospital, University of Antwerp, Antwerp, Belgium.
  • Grimmel M; Department of Clinical Genetics, Liverpool Hospital, Liverpool, NSW, Australia.
  • Haack TB; Children's Hospital at Westmead, Sydney Children's Hospitals Network, Sydney, Australia.
  • Clement E; Service de Génétique Clinique, Centre Hospitalier Régional Universitaire de Tours, Tours, France.
  • McTague A; Service de Génétique Clinique, Centre Hospitalier Régional Universitaire de Tours, Tours, France.
  • Hunt D; Genetic Center, Akron Children's Hospital, Akron, OH, USA.
  • Townshend S; Genetic Center, Akron Children's Hospital, Akron, OH, USA.
  • Ward M; Center of Medical Genetics, University Hospital Antwerp/University of Antwerp, Edegem, Belgium.
  • Richards LJ; Center of Medical Genetics, University Hospital Antwerp/University of Antwerp, Edegem, Belgium.
  • Simons C; Department of Pediatric Neurology, University Hospital Antwerp/University of Antwerp, Edegem, Belgium.
  • Costain G; Institute of Human Genetics, Heidelberg University, Heidelberg, Germany.
  • Dupuis L; Institute of Medical Genetics and Applied Genomics, University of Tuebingen, Tuebingen, Germany.
  • Mendoza-Londono R; Institute of Medical Genetics and Applied Genomics, University of Tuebingen, Tuebingen, Germany.
  • Dudding-Byth T; Department of Clinical Genetics, Great Ormond Street Hospital for Children, London, UK.
  • Boyle J; Developmental Neurosciences, UCL Great Ormond Street Institute of Child Health, London, UK.
  • Saunders C; Department of Neurology, Great Ormond Street Hospital, London, UK.
  • Fleming E; Wessex Clinical Genetics Service, Princess Anne Hospital, Southampton, UK.
  • El Chehadeh S; Genetic Services of WA, King Edward Memorial Hospital, Subiaco, WA, Australia.
  • Spitz MA; Genetic Services of WA, King Edward Memorial Hospital, Subiaco, WA, Australia.
  • Piton A; Department of Neuroscience, Washington University in St Louis School of Medicine, St Louis, MI, USA.
  • Gerard B; The University of Queensland, Queensland Brain Institute, St Lucia, QLD, Australia.
Mol Psychiatry ; 28(2): 668-697, 2023 02.
Article em En | MEDLINE | ID: mdl-36385166
ABSTRACT
Missense and truncating variants in the X-chromosome-linked CLCN4 gene, resulting in reduced or complete loss-of-function (LOF) of the encoded chloride/proton exchanger ClC-4, were recently demonstrated to cause a neurocognitive phenotype in both males and females. Through international clinical matchmaking and interrogation of public variant databases we assembled a database of 90 rare CLCN4 missense variants in 90 families 41 unique and 18 recurrent variants in 49 families. For 43 families, including 22 males and 33 females, we collated detailed clinical and segregation data. To confirm causality of variants and to obtain insight into disease mechanisms, we investigated the effect on electrophysiological properties of 59 of the variants in Xenopus oocytes using extended voltage and pH ranges. Detailed analyses revealed new pathophysiological mechanisms 25% (15/59) of variants demonstrated LOF, characterized by a "shift" of the voltage-dependent activation to more positive voltages, and nine variants resulted in a toxic gain-of-function, associated with a disrupted gate allowing inward transport at negative voltages. Functional results were not always in line with in silico pathogenicity scores, highlighting the complexity of pathogenicity assessment for accurate genetic counselling. The complex neurocognitive and psychiatric manifestations of this condition, and hitherto under-recognized impacts on growth, gastrointestinal function, and motor control are discussed. Including published cases, we summarize features in 122 individuals from 67 families with CLCN4-related neurodevelopmental condition and suggest future research directions with the aim of improving the integrated care for individuals with this diagnosis.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transtornos do Neurodesenvolvimento Limite: Female / Humans / Male Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transtornos do Neurodesenvolvimento Limite: Female / Humans / Male Idioma: En Ano de publicação: 2023 Tipo de documento: Article